Nab-paclitaxel and gemcitabine in soft tissue sarcoma: trial update
1 Просмотры
• 07/18/23
0
0
встраивать
administrator
Подписчики
Speaking from the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain, Yannis Metaxas, MD, Cantonal Hospital Grison, Chur, Switzerland, discusses the results from the phase I part of the phase I/II SAKK 57/16 trial (NCT03524898). This study investigated nab-paclitaxel and gemcitabine in soft tissue sarcoma.
Показать больше
Комментарии Facebook
SORT BY-
Лучшие комментарии
-
Последние комментарии